Rachel Lenington, COO and CDO at Athira Pharma, Inc. (ATHA), sold 2,525 shares at $0.57 ($1K) on 2024-09-05, disclosed to the SEC on 2024-09-05.
Open-market sale of $1k ATHA by COO and CDO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |